Interestingly, supplementation of obese patients with delayed-type nicotinic acid (vitamin B3) was shown to improve biomarkers for inflammation and systemic insulin sensitivity going along with an increase in the abundance of Bacteroidetes [193]: both inflammation and insulin resistance have been demonstrated to contribute importantly to neurodegeneration in AD [194]. Here, INS is linked to Alzheimer disease.